QuidelOrtho (QDEL) Competitors $27.06 +0.73 (+2.76%) As of 03:05 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock QDEL vs. MMSI, HAE, ICUI, XRAY, NEOG, STAA, CERS, OSUR, UTMD, and ANIKShould you be buying QuidelOrtho stock or one of its competitors? The main competitors of QuidelOrtho include Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Neogen (NEOG), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), and Anika Therapeutics (ANIK). These companies are all part of the "health care supplies" industry. QuidelOrtho vs. Its Competitors Merit Medical Systems Haemonetics ICU Medical DENTSPLY SIRONA Neogen STAAR Surgical Cerus OraSure Technologies Utah Medical Products Anika Therapeutics Merit Medical Systems (NASDAQ:MMSI) and QuidelOrtho (NASDAQ:QDEL) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends and institutional ownership. Which has more volatility and risk, MMSI or QDEL? Merit Medical Systems has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Comparatively, QuidelOrtho has a beta of 0.07, suggesting that its stock price is 93% less volatile than the S&P 500. Do analysts rate MMSI or QDEL? Merit Medical Systems currently has a consensus target price of $109.11, indicating a potential upside of 28.77%. QuidelOrtho has a consensus target price of $44.33, indicating a potential upside of 63.23%. Given QuidelOrtho's higher probable upside, analysts clearly believe QuidelOrtho is more favorable than Merit Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Merit Medical Systems 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89QuidelOrtho 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43 Do insiders and institutionals believe in MMSI or QDEL? 99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are owned by institutional investors. 3.2% of Merit Medical Systems shares are owned by insiders. Comparatively, 0.8% of QuidelOrtho shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is MMSI or QDEL more profitable? Merit Medical Systems has a net margin of 8.81% compared to QuidelOrtho's net margin of -12.07%. Merit Medical Systems' return on equity of 15.52% beat QuidelOrtho's return on equity.Company Net Margins Return on Equity Return on Assets Merit Medical Systems8.81% 15.52% 8.72% QuidelOrtho -12.07%4.71%2.21% Does the media refer more to MMSI or QDEL? In the previous week, QuidelOrtho had 2 more articles in the media than Merit Medical Systems. MarketBeat recorded 10 mentions for QuidelOrtho and 8 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.11 beat QuidelOrtho's score of 0.90 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive QuidelOrtho 4 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation & earnings, MMSI or QDEL? Merit Medical Systems has higher earnings, but lower revenue than QuidelOrtho. QuidelOrtho is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMerit Medical Systems$1.39B3.61$120.36M$2.0441.54QuidelOrtho$2.78B0.66-$2.05B-$4.97-5.46 SummaryMerit Medical Systems beats QuidelOrtho on 13 of the 16 factors compared between the two stocks. Get QuidelOrtho News Delivered to You Automatically Sign up to receive the latest news and ratings for QDEL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QDEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QDEL vs. The Competition Export to ExcelMetricQuidelOrthoMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.83B$10.44B$5.71B$9.51BDividend YieldN/A2.00%4.60%3.99%P/E Ratio-5.4517.0128.0720.02Price / Sales0.6626.84459.47103.02Price / Cash0.7523.2136.5558.97Price / Book0.613.648.615.88Net Income-$2.05B$234.77M$3.24B$258.50M7 Day Performance6.72%5.69%3.83%2.03%1 Month Performance-3.38%7.60%10.40%12.52%1 Year Performance-28.97%-14.07%34.13%19.07% QuidelOrtho Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QDELQuidelOrtho4.4662 of 5 stars$27.06+2.8%$44.33+63.9%-31.4%$1.83B$2.78B-5.456,600MMSIMerit Medical Systems4.1255 of 5 stars$93.450.0%$109.11+16.8%-3.2%$5.52B$1.36B45.817,400Positive NewsUpcoming EarningsHAEHaemonetics4.9081 of 5 stars$76.59+1.4%$97.30+27.0%-18.9%$3.68B$1.36B23.143,023Positive NewsICUIICU Medical4.3575 of 5 stars$130.85-1.0%$192.67+47.2%+2.6%$3.22B$2.42B-34.1615,000News CoveragePositive NewsXRAYDENTSPLY SIRONA4.0856 of 5 stars$16.00-1.3%$20.36+27.3%-37.3%$3.19B$3.72B-3.5214,000Upcoming EarningsAnalyst ForecastNEOGNeogen4.0279 of 5 stars$5.22-3.2%$7.50+43.7%-69.6%$1.13B$924.22M-2.342,110Trending NewsUpcoming EarningsAnalyst RevisionSTAASTAAR Surgical2.6867 of 5 stars$17.30-0.5%$24.63+42.3%-54.2%$856.87M$313.90M-12.011,211Positive NewsCERSCerus2.8641 of 5 stars$1.45flat$3.50+141.4%-41.1%$277.18M$185.14M-14.50290Positive NewsUpcoming EarningsOSUROraSure Technologies2.4917 of 5 stars$3.07-1.0%$3.00-2.3%-23.5%$229.64M$185.83M-7.31840Positive NewsHigh Trading VolumeUTMDUtah Medical Products1.9418 of 5 stars$56.69+0.5%N/A-22.6%$184.24M$40.90M15.00180News CoveragePositive NewsEarnings ReportANIKAnika Therapeutics4.1398 of 5 stars$11.53+2.3%$20.00+73.5%-59.7%$165.35M$117.05M-2.97300 Related Companies and Tools Related Companies Merit Medical Systems Alternatives Haemonetics Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Neogen Alternatives STAAR Surgical Alternatives Cerus Alternatives OraSure Technologies Alternatives Utah Medical Products Alternatives Anika Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QDEL) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding QuidelOrtho Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share QuidelOrtho With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
